fda warning bpc 157 not approved FDA's Overreach on Compounded Peptides EVEXIAS Life Sciences filing lawsuit
Description
Not because of safety concerns per se, but because it becomes impossible to know whats actually working
- recommend reducing intervention frequency if B12 levels are elevated, and continue to monitor
Two weeks of late nights, heavy meals, skipped workouts, and more alcohol than you care to admit have left you bloated, sluggish, and wondering where your energy went
As discussed, GLP-1 therapy creates a real risk of B12 depletion over time
